Location History:
- Oakland, CA (US) (2004)
- San Francisco, CA (US) (2004 - 2006)
Company Filing History:
1 out of 63 
2 out of 832,843 Years Active: 2004-2006
Title: Douglas R Cary: Innovator in Fluorescent Sensing Technologies
Introduction
Douglas R Cary is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of fluorescent sensing technologies, holding a total of 3 patents. His work focuses on developing innovative compounds that enhance the detection of various analytes.
Latest Patents
Cary's latest patents include advancements in aspartyl protease inhibitors and glucose sensing molecules. The aspartyl protease inhibitors are designed to provide effective compounds that can inhibit specific proteases. The glucose sensing molecules utilize intramolecular electron transfer to exhibit selected fluorescent properties in the presence of saccharides. These properties include excitation wavelength, emission wavelength, fluorescence lifetime, quantum yield, photostability, solubility, and sensitivity to temperature or pH. The compounds are typically based on aryl or substituted phenyl boronic acids, which serve as substrate recognition components, fluorescence switch components, and fluorophores. The fluorophores are chosen to ensure optimal performance in glucose detection, particularly for applications involving optical transmission through skin.
Career Highlights
Throughout his career, Douglas R Cary has worked with various companies, including Sunesis Pharmaceuticals, Inc. His innovative work has positioned him as a key figure in the development of advanced sensing technologies.
Collaborations
Cary has collaborated with notable professionals in his field, including Joe H Satcher, Jr. and Stephen M Lane. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Douglas R Cary's contributions to the field of fluorescent sensing technologies highlight his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a commitment to improving detection methods, particularly in the realm of glucose monitoring.